| Trial ID: | L6035 |
| Source ID: | NCT05709938
|
| Associated Drug: |
Glargine And Regular Insulin Versus Nph And Regular Insulin
|
| Title: |
Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
|
| Interventions: |
DRUG: Glargine and regular insulin versus NPH and regular insulin
|
| Outcome Measures: |
Primary: HbA1c, Baseline HbA1c is compared with the end HbA1c after 3 months of therapy, Three months|Hypoglycemia, Capillary blood sugar level below 70mg/dl, Three months|Fasting blood sugar, Capillary blood sugar before breakfast, Three months|Post-meal blood, Capillary blood sugar level 2 hours after the three main meals, Three months|Mid night blood glucose level, Capillary blood glucose levels between 12:00am -3:00am, Three months |
|
| Sponsor/Collaborators: |
Sponsor: King Edward Medical University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
68
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2019-11-01
|
| Completion Date: |
2021-04-20
|
| Results First Posted: |
|
| Last Update Posted: |
2023-02-02
|
| Locations: |
Pediatric endocrine and diabetes section, Pediatric department, Mayo Hospital, Lahore, Punjab, 54000, Pakistan
|
| URL: |
https://clinicaltrials.gov/show/NCT05709938
|
